ALB and cancer: In MDR cancers, where resistance mechanisms such as drug efflux pumps limit the effectiveness of conventional chemotherapeutics, the dual interaction of metallodrugs with HSA and DNA offers promising strategies to improve drug delivery and overcome resistance.